Skip to main content
SpringerLink
Log in

Neuropeptide Y and the heart: implication for myocardial infarction and heart failure

  • Chapter
NPY Family of Peptides in Neurobiology, Cardiovascular and Metabolic Disorders: from Genes to Therapeutics

Part of the book series: Experientia Supplementum ((EXS,volume 95))

  • 463 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Tatemoto K (1982) Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 79: 5485–5489

    CAS  PubMed  Google Scholar 

  2. Tatemoto K (1982) Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA 79: 2514–2518

    CAS  PubMed  Google Scholar 

  3. Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y — a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296: 659–660

    Article  CAS  PubMed  Google Scholar 

  4. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar RD, Quirion R, Schwartz T, Westfall T (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50: 143–150

    CAS  PubMed  Google Scholar 

  5. Allen J, Novotny J, Martin J, Heinrich G (1987) Molecular structure of mammalian neuropeptide Y: analysis by molecular cloning and computer-aided comparison with crystal structure of avian homologue. Proc Natl Acad Sci USA 84: 2532–2536

    CAS  PubMed  Google Scholar 

  6. MacKerell AD Jr, (1981) Molecular modeling and dynamics of neuropeptide Y. J Comput Aided Mol Des 2: 55–63

    Google Scholar 

  7. Blundell TL, Pitts JE, Tickle IJ, Wood SP (1981) The conformation and receptor binding of pancreatic hormones. Biochem Soc Trans 9: 31–32

    CAS  PubMed  Google Scholar 

  8. Glover I, Haneef I, Pitts J, Wood S, Moss D, Tickle I, Blundell T (1983) Conformational flexibility in a small globular hormone: x-ray analysis of avian pancreatic polypeptide at 0.98-A resolution. Biopolymers 22: 293–304

    Article  CAS  PubMed  Google Scholar 

  9. Chan-Palay V, Allen YS, Lang W, Haesler U, Polak JM (1985) Cytology and distribution in normal human cerebral cortex of neurons immunoreactive with antisera against neuropeptide Y. J Comp Neurol 238: 382–389

    CAS  PubMed  Google Scholar 

  10. Chronwall BM, Di Maggio DA, Massari VJ, Pickel VM, Ruggiero DA, O’Donohue TL (1985) The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15: 1159–1181

    Article  CAS  PubMed  Google Scholar 

  11. de Quidt ME, Emson PC (1986) Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system — II. Immunohistochemical analysis. Neuroscience 18: 545–618

    PubMed  Google Scholar 

  12. Dumont Y, Martel JC, Fournier A, St-Pierre S, Quirion R (1992) Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol 38: 125–167

    Article  CAS  PubMed  Google Scholar 

  13. O’Donohue TL, Chronwall BM, Pruss RM, Mezey E, Kiss JZ, Eiden LE, Massari VJ, Tessel RE, Pickel VM, Di Maggio DA et al. (1985) Neuropeptide Y and peptide YY neuronal and endocrine systems. Peptides 6: 755–768

    CAS  PubMed  Google Scholar 

  14. McDonald JK (1988) NPY and related substances. Crit Rev Neurobiol 4: 97–135

    CAS  PubMed  Google Scholar 

  15. Solomon TE (1985) Pancreatic polypeptide, peptide YY, and neuropeptide Y family of regulatory peptides. Gastroenterology 88: 838–841

    CAS  PubMed  Google Scholar 

  16. Ekman R, Wahlestedt C, Bottcher G, Sundler F, Hakanson R, Panula P (1986) Peptide YY-like immunoreactivity in the central nervous system of the rat. Regul Pept 16: 157–168

    Article  CAS  PubMed  Google Scholar 

  17. Hare JM (1999) Etiologic basis of congestive heart failure. In: Atlas of Heart Failure, Cardiac Function and Dysfunction Colucci WS, Braunwald E (Eds) Current Medicine Inc., Philadelphia

    Google Scholar 

  18. Mann DL (2005) Heart failure as a progressive disease. In Heart Failure, A Companion to Braunwald’s Heart Disease Mann DL (Ed) Saunders 123–128

    Google Scholar 

  19. Packer M (1992) The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20: 248–254

    CAS  PubMed  Google Scholar 

  20. Effects of enalapril on mortality in severe congestive heart failure (1987) Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316: 1429–1435

    Google Scholar 

  21. Gheorghiade M, Lukas MA (2004) Role of carvedilol in atrial fibrillation: insights from clinical trials. Am J Cardiol 93: 53B–7B

    CAS  PubMed  Google Scholar 

  22. Burnett JC Jr, Costello-Boerrigter L, Boerrigter G (2004) Alterations in the kidney in heart failure: the Cardiorenal Axis in the regulation of Sodium Homeostasis. In: Heart Failure, A Companion to Braunwald’s Heart Disease Mann DL (Ed) Saunders 279–289

    Google Scholar 

  23. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perezz A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709–717

    CAS  PubMed  Google Scholar 

  24. Onuoha GN, Nicholls DP, Alpar EK, Ritchie A, Shaw C, Buchanan K (1999) Regulatory peptides in the heart and major vessels of man and mammals. Neuropeptides 33: 165–172

    CAS  PubMed  Google Scholar 

  25. Sundler F, Bottcher G, Ekbald E, Hakanson R (1993) PP, PYY and NPY occurrence and distribution in the periphery. In: The Biology of Neuropeptide Y and related paptides Colmers WF, Wahlested C (Eds) Humana Press, 157–196

    Google Scholar 

  26. Allen CJ, Ghilardi JR, Vigna SR, Mannon PJ, Taylor IL, McVey DC, Maggio JE, Mantyh PW (1993) Neuropeptide Y/peptide YY receptor binding sites in the heart: localization and pharmacological characterization. Neuroscience 53: 889–898

    Article  CAS  PubMed  Google Scholar 

  27. McDermott BJ, Millar BC, Dolan FM, Bell D, Balasubramaniam A (1997) Evidence for Y1 and Y2 subtypes of neuropeptide Y receptors linked to opposing postjunctional effects observed in rat cardiac myocytes. Eur J Pharmacol 336: 257–265

    Article  CAS  PubMed  Google Scholar 

  28. Lundberg JM (1996) Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48: 113–178

    CAS  PubMed  Google Scholar 

  29. Jonsson-Rylander AC, Nordlander M, Svindland A, Ilebekk A (2003) Distribution of neuropeptide Y Y1 and Y2 receptors in the postmortem human heart. Peptides 24: 255–262

    CAS  PubMed  Google Scholar 

  30. Potter E (1987) Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y. Neurosci Lett 83: 101–106

    Article  CAS  PubMed  Google Scholar 

  31. Abrahamsson C (2000) Neuropeptide Y1-and Y2-receptor-mediated cardiovascular effects in the anesthetized guinea pig, rat, and rabbit. J Cardiovasc Pharmacol 36: 451–458

    CAS  PubMed  Google Scholar 

  32. Doods H, Gaida W, Wieland HA, Dollinger H, Schnorrenberg G, Esser F, Engel W, Eberlein W, Rudolf K (1999) BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur J Pharmacol 384: R3–5

    Article  CAS  PubMed  Google Scholar 

  33. Smith-White MA, Hardy TA, Brock JA, Potter EK (2001) Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions. Br J Pharmacol 132: 861–868

    Article  CAS  PubMed  Google Scholar 

  34. Clarke JG, Davies GJ, Kerwin R, Hackett D, Larkin S, Dawbarn D, Lee Y, Bloom SR, Yacoub M, Maseri A (1987) Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet 1: 1057–1059

    CAS  PubMed  Google Scholar 

  35. Gullestad L, Jorgensen B, Bjuro T, Pernow J, Lundberg JM, Dota CD, Hall C, Simonsen S, Ablad B (2000) Postexercise ischemia is associated with increased neuropeptide Y in patients with coronary artery disease. Circulation 102: 987–993

    CAS  PubMed  Google Scholar 

  36. Lee EW, Tilan JU, Kuo J, Zukowska Z (2005) NTY as a mediator of neurogenic angiogenesis and revascularization of ischemic tissues. In: Z Zukowska, GZ Feuerstein (eds): The NPY family of peptides in immune disorders, inflammation, angiogenesis and cancer. Birkhäuser, Basel, 151–166

    Google Scholar 

  37. Liu JJ, Shi SG, Han QD (1994) Evaluation of plasma neuropeptide Y levels in patients with congestive heart failure. Zhonghua Nei Ke Za Zhi 33: 687–689

    CAS  PubMed  Google Scholar 

  38. Madsen BK, Husum D, Videbaek R, Stokhlm KH, Saelsen L, Christensen NJ (1993) Plasma immunoreactive neuropeptide Y in congestive heart failure at rest and during exercise. Scand J Clin Lab Invest 53: 569–576

    CAS  PubMed  Google Scholar 

  39. Ullman B, Jensen-Urstad M, Hulting J, Lundberg JM (1993) Neuropeptide Y, noradrenaline and invasive haemodynamic data in mild to moderate chronic congestive heart failure. Clin Physiol 13: 409–418

    CAS  PubMed  Google Scholar 

  40. Ullman B, Hulting J, Lundberg JM (1994) Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction. Eur Heart J 15: 454–461

    CAS  PubMed  Google Scholar 

  41. Anderson FL, Port JD, Reid BB, Larrabee P, Hanson G, Bristow MR (1992) Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation. Circulation 85: 46–53

    CAS  PubMed  Google Scholar 

  42. Mertes PM, El-Abbassi K, Jaboin Y, Michel C, Beck B, Pinelli G, Carteaux JP, Villemot JP, Burlet C (1996) Consequences of coronary occlusion on changes in regional interstitial myocardial neuropeptide Y and norepinephrine concentrations. J Mol Cell Cardiol 28: 1995–2004

    Article  CAS  PubMed  Google Scholar 

  43. Lee EW, Callanan EY, Winaver J, Haramati A, Zukowska Z (2005) A role of neuropeptide Y (NPY) and NPY receptors in congestive heart failure. Am J Physiol Heart Circ Physiol; submitted

    Google Scholar 

  44. Pons J, Kitlinska J, Ji H, Lee EW, Zukowska Z (2003) Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can J Physiol Pharmacol 81: 177–185

    Article  CAS  PubMed  Google Scholar 

  45. Li L, Lee EW, Ji H, Zukowska Z (2003) Neuropeptide Y-Induced Acceleration of Postangioplasty Occlusion of Rat Carotid Artery. Arterioscler Thromb Vasc Biol 23: 1204–1210

    CAS  PubMed  Google Scholar 

  46. Millar BC, Schluter KD, Zhou XJ, McDermott BJ, Piper HM (1994) Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes. Am J Physiol 266: C1271–1277

    CAS  PubMed  Google Scholar 

  47. Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, Sangkharat A, Ji H, Li L, Michalkiewicz T, Ljubisavljevic M, Johansson H, Grant DS, Zukowska Z (2003) Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 111: 1853–1862

    CAS  PubMed  Google Scholar 

  48. Zelis R, Nussberger J, Clemson B, Waeber B, Grouzmann E, Brunner HR (1994) Neuropeptide Y infusion decreases plasma renin activity in postmyocardial infarction rats. J Cardiovasc Pharmacol 24: 896–899

    CAS  PubMed  Google Scholar 

  49. Waeber B, Evequoz D, Aubert JF, Fluckiger JP, Juillerat L, Nussberger J, Brunner HR (1990) Prevention of renal hypertension in the rat by neuropeptide Y. J Hypertens 8: 21–25

    CAS  PubMed  Google Scholar 

  50. Pfister A, Waeber B, Nussberger J, Brunner HR (1986) Neuropeptide Y normalizes renin secretion in adrenalectomized rats without changing blood pressure. Life Sci 39: 2161–2167

    Article  CAS  PubMed  Google Scholar 

  51. Lundberg JM, Franco-Cereceda A, Lacroix JS, Pernow J (1990) Neuropeptide Y and sympathetic neurotransmission. Ann NY Acad Sci 611: 166–174

    CAS  PubMed  Google Scholar 

  52. Allen JM, Raine AE, Ledingham JG, Bloom SR (1985) Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. Clin Sci 68: 373–377

    CAS  PubMed  Google Scholar 

  53. Waeber B, Burnier M, Nussberger J, Brunner HR (1990) Role of atrial natriuretic peptides and neuropeptide Y in blood pressure regulation. Horm Res 34: 161–165

    CAS  PubMed  Google Scholar 

  54. Balasubramaniam A (2002) Clinical potentials of neuropeptide Y family of hormones. Am J Surg 183: 430–434

    Article  CAS  PubMed  Google Scholar 

  55. Kanevskij M, Taimor G, Schafer M, Piper HM, Schluter KD (2002) Neuropeptide Y modifies the hypertrophic response of adult ventricular cardiomyocytes to norepinephrine. Cardiovasc Res 53: 879–887

    Article  CAS  PubMed  Google Scholar 

  56. Feng Q, Sun X, Lu X, Edvinsson L, Hedner T (1999) Decreased responsiveness of vascular postjunctional alpha1-, alpha2-adrenoceptors and neuropeptide Y1 receptors in rats with heart failure. Acta Physiol Scand 166: 285–291

    Article  CAS  PubMed  Google Scholar 

  57. Zukowska Z, Grant DS, Lee EW (2003) Neuropeptide Y: a novel mechanism for ischemic angiogenesis. Trends Cardiovasc Med 13: 86–92

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Translational Sciences, Wyeth Research, Collegeville, PA, 19426, USA

    Giora Z. Feuerstein & Edward W. Lee

Authors
  1. Giora Z. Feuerstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edward W. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Physiology and Biophysics, Georgetown University Medical Center, 3900 Reservoir Rd., NW, Washington, DC, 20057, USA

    Zofia Zukowska

  2. Wyeth Research, Building A3153, 500 Arcola Rd, Collegeville, PA, 19426, USA

    Giora Z. Feuerstein

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag/Switzerland

About this chapter

Cite this chapter

Feuerstein, G.Z., Lee, E.W. (2006). Neuropeptide Y and the heart: implication for myocardial infarction and heart failure. In: Zukowska, Z., Feuerstein, G.Z. (eds) NPY Family of Peptides in Neurobiology, Cardiovascular and Metabolic Disorders: from Genes to Therapeutics. Experientia Supplementum, vol 95. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7417-9_8

Download citation

Publish with us

Policies and ethics

Search

Navigation